Turnstone Biologics
La Jolla
About Turnstone Biologics
Turnstone Biologics is a privately-held clinical-stage biotech company. Turnstone Biologics’ mission is to deliver breakthrough cancer immunotherapies by advancing two leading and complementary platforms targeting tumor immunity, to improve survival for people with cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $132.7M
- Funding stage: M&A
- Last round: Series D (Jul 2021)
- Ticker: nasdaq:TSBX
- Website: turnstonebio.com
- Phone: (613)421-8930
Industries & Categories
Biotechnology, Innovation Management, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/turnstone-biologics-43353 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.